The skin is the body’s largest immune organ. We study how it fights, fails, and heals.

We work on inflammasome biology, caspase signaling, and immune metabolism — in S. aureus infection, atopic dermatitis, and psoriasis. The goal is biomarkers and host-directed therapies for disease that antibiotics can no longer reach.

Department

Dermatology

Institution

Johns Hopkins Medicine

Location

Baltimore, Maryland

Research programs

01

Antibiotic resistance

Host-directed alternatives to antibiotics for MRSA and other bacterial skin infections.

02

Immunometabolism

How immune cell metabolism shapes function, inflammation, and bacterial clearance.

03

Inflammatory skin disease

Mechanisms in atopic dermatitis, psoriasis, and prurigo nodularis.

04

Tissue regeneration

Repair and regeneration of skin following infection and injury.

Explore our research →

The burden we work against

S. aureus is the leading bacterial cause of death worldwide. Since 1990 its global toll has risen by 82%, while P. aeruginosa has risen 16% — opening a gap that barely existed three decades ago.

See how these organisms rank, and what we do about it →

Recent from the lab

Drug Development Research · 2023

An oral caspase inhibitor as monotherapy or with antibiotics eradicates MRSA skin infections in mice

Cahill E, Oladipo OO, Dikeman D, Prifti D, Mento SJ, Miller LS, Alphonse MP

All publications →